New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk

BACKGROUND: The use of estrogen plus progestin therapy increases both breast cancer incidence and breast tenderness. Whether breast tenderness during estrogen plus progestin therapy is associated with breast cancer risk is uncertain. METHODS: We analyzed data from the Women’s Health Initiative Estro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Crandall, Carolyn J., Aragaki, Aaron K., Chlebowski, Rowan T., McTiernan, Anne, Anderson, Garnet, Hendrix, Susan L., Cochrane, Barbara B., Langer, Robert D., Kuller, Lewis H., Cauley, Jane A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2009
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3670683/
https://ncbi.nlm.nih.gov/pubmed/19822825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archinternmed.2009.303
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares